Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Personalized Motor Plasticity in Glioma
NCT06381726Recruiting
- Sponsor
- University of Milan
- Start
- Mar 2024
- Primary completion
- Feb 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of temozolomide in glioma (4 arms), sponsored by University of Milan. Primary endpoints: Muscle power and Motor praxia. Started Mar 2024; status: recruiting.
02
Drugs
temozolomide
03
Conditions
glioma
Beyond the preview
Go deeper on NCT06381726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06381726.